Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDRH Science Office Reorganization Eliminates Branches, Focuses On Labs

This article was originally published in The Gray Sheet

Executive Summary

The device center's Office of Science & Technology is set to unveil organizational changes, following efforts to revamp the office based on internal and external program reviews

You may also be interested in...



CDRH Science Office Will Team With Industry On Internal Research Agenda

CDRH's Office of Science & Engineering Laboratories will consult with industry and academia experts in a fall evaluation of device research projects, according to Director Larry Kessler

CDRH Science Office Will Team With Industry On Internal Research Agenda

CDRH's Office of Science & Engineering Laboratories will consult with industry and academia experts in a fall evaluation of device research projects, according to Director Larry Kessler

AdvaMed Device Submissions Workshop In Brief

MR compatibility: CDRH's science office plans development of "guidance and standards that will help manufacturers figure out MRI compatibility with devices," CDRH Deputy Director Linda Kahan tells participants at AdvaMed's 14th Annual Device Submissions Workshop June 3-4 in Arlington, Va. MR compatibility "is something that we find has held up applications for products," and the initiative is meant to speed reviews. The Office of Science & Engineering Laboratories (formerly the Office of Science & Technology) was reorganized this year ("1The Gray Sheet" March 15, 2004, p. 8)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019899

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel